Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
|
|
ACETO CORP (ACETQ)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/01/2019 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 10/01/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/01/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/01/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/01/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/01/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/01/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/01/2019 |
8-K
| Bankruptcy or Receivership, Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or ... |
| 09/20/2019 |
8-K
| Bankruptcy or Receivership, Material Modifications to Rights of Security Holders, Departure of Directors or Certain Officers;... |
| 08/26/2019 |
8-K
| Other Events, Financial Statements and Exhibits |
| 08/20/2019 |
RW
| Form RW - Registration Withdrawal Request: |
| 08/15/2019 |
8-K
| Quarterly results |
| 08/02/2019 |
8-K
| Other Events, Financial Statements and Exhibits |
| 07/16/2019 |
8-K
| Other Events, Financial Statements and Exhibits |
| 07/02/2019 |
8-K
| Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Financial Statements and Ex... |
| 06/18/2019 |
8-K
| Quarterly results |
| 06/05/2019 |
8-K/A
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o... |
| 06/03/2019 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o... |
| 06/03/2019 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 05/17/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/03/2019 |
8-K
| Termination of a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointmen... |
| 04/30/2019 |
8-K
| Completion of Acquisition or Disposition of Assets |
| 04/25/2019 |
8-K
| Completion of Acquisition or Disposition of Assets |
| 04/22/2019 |
GN
| ACETO Completes the Sale of Rising Pharmaceuticals |
| 04/17/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/15/2019 |
GN
| ACETO to Sell its Chemicals Business Assets to New Mountain Capital |
| 04/15/2019 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"ACETO Receives Court Approval of “Stalking Horse” Agreement to Sell Rising Pharmaceuticals to Shore Suven Pharma, Inc. PORT WASHINGTON, N.Y., April 12, 2019 -- ACETO Corporation, an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has received approval from the U.S. Bankruptcy Court to sell the assets of Rising Pharmaceuticals and Rising’ s subsidiaries to Shore Suven Pharma, Inc. for gross cash proceeds of $15 million, plus the assumption of operating liabilities and customer obligations related to the acquired business, on a cash-free and debt-free basis. The sale was conducted through a Court-supervised process under Section 363 of the Bankruptcy Code..." |
|
| 04/12/2019 |
GN
| ACETO Receives Court Approval of “Stalking Horse” Agreement to Sell Rising Pharmaceuticals to Shore Suven Pharma, Inc. |
| 04/03/2019 |
8-K
| Quarterly results |
| 04/02/2019 |
8-K/A
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
| 04/01/2019 |
8-K
| Entry into a Material Definitive Agreement |
| 03/08/2019 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits|
Docs:
|
"Asset Purchase Agreement, by and among Rising Pharmaceuticals, Inc., PACK Pharmaceuticals, LLC, Rising Health, LLC, Acetris Health, LLC, as sellers, Aceto Corporation, as parent, and Shore Suven Pharma, Inc., as buyer",
"Equity Commitment Letter, by and between (i) Suven Life Sciences, Ltd., Vimal Kavuru, Shore Pharma Investments, LLC, and Casper Pharma Private Limited, and (ii) Shore Suven Pharma, Inc",
"Mutual Release of Claims, by and between (i) Aceto Corporation, Rising Pharmaceuticals, Inc., Acetris Health, LLC, and Rising Health, LLC, and (ii) Shore Pharma LLC, Cedar Pharma LLC (f/k/a Citron Pharma LLC), Aster Pharma LLC (f/k/a Lucid Pharma LLC), Citgen Pharma Holding LLC, Gensource Pharma LLC, SS Pharma LLC, Pharma Reach LLC, Citgen Realty LLC, Sudha Kavuru, Vimal Kavuru and Subha Sri Thogarchedu" |
|
| 03/07/2019 |
GN
| ACETO Enters into “Stalking Horse” Agreement to Sell Rising Pharmaceuticals |
| 02/22/2019 |
8-K
| Quarterly results |
|
|
|